Production of pharmaceutical actives through biotechnology is in the patient’s best interest

The introduction of biotechnology for production of active substances in bacteria and / or cells was a milestone for the pharmaceutical industry. With these new processes, highly potent substances can be produced in sufficient volumes, something that conventional preparation could not achieve.

We prove the potency of such biotech pharma products in line with the European Pharmacopoeia, under GMP since 2008.

WordPress Cookie Plugin by Real Cookie Banner